Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
BioCryst Pharmaceuticals, Inc. is a global biotechnology company specializing in structure-guided drug design to develop oral small-molecule and injectable protein therapeutics for rare diseases. Its key products include ORLADEYO, an oral treatment for hereditary angioedema, and peramivir injection for influenza. BioCryst targets niche markets with high unmet medical needs, leveraging proprietary technology and strategic partnerships to advance drug candidates from discovery through commercialization.
This description was generated via AI from an annual report. Updated about 1 year ago.